Tick vaccines and the transmission of tick-borne pathogens

Veterinary Research Communications

Volumn 31, Issue SUPPL. 1, 2007, Pages 85-90

  Fuente, Jose ^a,b   Kocan, K M ^a   Blouin, E F ^a  

^a OKLAHOMA STATE UNIVERSITY   (United States)

^b INSTITUTO DE INVESTIGACIÓN EN RECURSOS CINEGÉTICOS IREC CSIC UCLM JCCM   (Spain)

Author keywords

4D8; 64P; Koch's postulates; RNA interference; Subolesin; TROSPA

Indexed keywords

BACTERIAL VACCINE; OUTER SURFACE PROTEIN A; RECOMBINANT 64P ANTIGEN; RECOMBINANT ANTIGEN; RECOMBINANT BM86 ANTIGEN; RECOMBINANT SUBOLESIN; RECOMBINANT VACCINE; UNCLASSIFIED DRUG;

ANAPLASMA MARGINALE; ANAPLASMOSIS; ANIMAL DISEASE; ARTICLE; BORRELIA INFECTION; DISEASE CARRIER; DISEASE TRANSMISSION; DRUG EFFICACY; DRUG TARGETING; FEASIBILITY STUDY; HOST SUSCEPTIBILITY; IMMUNIZATION; INFECTION CONTROL; INFESTATION; INSECT CONTROL; IXODES SCAPULARIS; NONHUMAN; RISK REDUCTION; TICK; TICK BORNE DISEASE;

ANIMALS; TICK INFESTATIONS; TICK-BORNE DISEASES; TICKS; VACCINES;

ANIMALIA; BOOPHILUS; IXODIDA;

EID: 34547830937     PISSN: 01657380     EISSN: None     Source Type: Journal    
DOI: 10.1007/s11259-007-0069-5     Document Type: Article

References (20)

1. de la Fuente J. and Kocan K.M., 2003. Advances in the identification and characterization of protective antigens for development of recombinant vaccines against tick infestations. Expert Review of Vaccines, 2, 583-593
2. de la Fuente J. and Kocan K.M., 2006. Strategies for development of vaccines for control of ixodid tick species. Parasite Immunology, 28, 275-283
3. de la Fuente J., Rodriguez M., Redondo M., Montero C., García-García J.C., Méndez L., Serrano E., Valdés M., Enriquez A., Canales M., Ramos E., Boué O., Machado H., Lleonart R., de Armas C.A., Rey S., Rodríguez J.L., Artiles M., García L., 1998. Field studies and cost-effectiveness analysis of vaccination with Gavac™ against the cattle tick Boophilus microplus. Vaccine, 16, 366-373
4. de la Fuente J., Almazán C., Blouin E.F., Naranjo V., Kocan K.M., 2006a. Reduction of tick infections with Anaplasma marginale and A. phagocytophilum by targeting the tick protective antigen subolesin. Parasitology Research, in press
5. de la Fuente J., Canales M., Kocan K.M., 2006b. The importance of protein glycosylation in development of novel tick vaccine strategies. Parasite Immunology, in press
6. Dinglasan R.R. and Jacobs-Lorena M., 2005. Insight into a conserved lifestyle: Protein-carbohydrate adhesion strategies of vector-borne pathogens. Infection and Immunity, 73, 7797-7807
7. Estrada-Peña A. and Jongejan F., 1999. Ticks feeding on humans: A review of records on human-biting Ixodoidea with special reference to pathogen transmission. Experimental and Applied Acarology, 23, 685-715
8. Graf J.F., Gogolewski R., Leach-Bing N., Sabatini G.A., Molento M.B., Bordin E.L., Arantes G.J., 2004. Tick control: An industry point of view. Parasitology, 129, S427-S442
9. Gomes-Solecki M.J.C., Brisson D.R., Dattwyler R.J., 2006. Oral vaccine that breaks the transmission cycle of the Lyme disease spirochete can be delivered via bait. Vaccine, 24, 4440-4449
10. Grimes J., 2006. Koch's postulates - Then and now. Microbe, 1, 223-228
11. Koch R., 1884. Die Aetiologie der Tuberkulose. Mittheilungen aus dem Kaiserlichen Gesundheitsamte, 2, 1-88
12. Labuda M., Trimnell A.R., Lickova M., Kazimirova M., Davies G.M., Lissina O., Hails R.S., Nuttall P.A., 2006. An Antivector Vaccine Protects against a Lethal Vector-Borne Pathogen. PLoS Pathogens, 2(4), e27
13. Nuttall P.A., Trimnell A.R., Kazimirova M., Labuda M., 2006. Exposed and concealed antigens as vaccine targets for controlling ticks and tick-borne diseases. Parasite Immunology, 28, 155-163
14. Pal U., Li X., Wang T., Montgomery R.R., Ramamoorthi N., Desilva A.M., Bao F., Yang X., Pypaert M., Pradhan D., Kantor F.S., Telford S., Anderson J.F., Fikrig E., 2004. TROSPA, an Ixodes scapularis receptor for Borrelia burgdorferi. Cell, 119, 457-468
15. Parola P. and Raoult D., 2001. Tick-borne bacterial diseases emerging in Europe. Clinical Microbiology and Infection, 7, 80-83
16. Rodríguez Valle M., Méndez L., Valdez M., Redondo M., Espinosa C.M., Vargas M., Cruz R.L., Barrios H.P., Seoane G., Ramírez E.S., Boué O., Vigil J.L., Machado H., Nordelo C.B., Piñeiro M.J., 2004. Integrated control of Boophilus microplus ticks in Cuba based on vaccination with the anti-tick vaccine Gavac. Experimental and Applied Acarology, 34, 375-382
17. Sukumaran B., Narasimhan S., Anderson J.F., DePonte K., Marcantonio N., Krishnan M.N., Fish D., Telford S.R., Kantor F.S., Fikrig E., 2006. An Ixodes scapularis protein required for survival of Anaplasma phagocytophilum in tick salivary glands. Journal of Experimental Medicine, 203, 1507-1517
18. Tsao J.I., Wootton J.T., Bunikis J., Luna M.G., Fish D., Barbour A.G., 2004. An ecological approach to preventing human infection: Vaccinating wild mouse reservoirs intervenes in the Lyme disease cycle. Proceedings of the National Academy of Sciences U S A, 101, 18159-18164
19. Willadsen P., 2004. Anti-tick vaccines. Parasitology, 129, S367-387
20. Willadsen P., 2006. Tick control: Thoughts on a research agenda. Veterinary Parasitology, 138, 161-168